Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22466312 | 1.00 | LMNA (0.31) | LMNA | |
| SCHEMBL31545657 | 0.70 | — | — | |
| SCHEMBL6879361 | 0.70 | — | — | |
| SCHEMBL30105717 | 0.70 | — | — | |
| SCHEMBL5502133 | 0.70 | — | — | |
| SCHEMBL3854154 | 0.67 | LMNA (0.31) | LMNA | |
| SCHEMBL43215 | 0.65 | — | — | |
| SCHEMBL18475143 | 0.65 | — | — | |
| SCHEMBL505931 | 0.64 | — | — | |
| SCHEMBL1920338 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240010589-A1 | SUBSTITUTED RESORCINOL COMPOUNDS AS AMPK ACTIVATORS, COMPOSITIONS, METHODS AND USES THEREOF | NESTLE SA (CH) | 2024-01-11 | — | — | US | claimed |
| CN-116744911-A | Substituted resorcinol compounds as AMPK activators, compositions, methods and uses thereof | 雀巢产品有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-111448180-B | Preparation of acetate compounds by ketene compounds | 巴斯夫欧洲公司 | 2023-08-15 | — | — | CN | claimed |
| US-11091424-B2 | Preparation of acetate compounds via a ketene compound | BASF SE (DE) | 2021-08-17 | — | — | US | claimed |
| EP-3728179-A1 | PREPARATION OF ACETATE COMPOUNDS VIA A KETENE COMPOUND | BASF SE (DE) | 2020-10-28 | — | — | EP | claimed |
| US-20200308094-A1 | PREPARATION OF ACETATE COMPOUNDS VIA A KETENE COMPOUND | BASF SE (DE) | 2020-10-01 | — | — | US | claimed |
| CN-111448180-A | Preparation of acetate compounds by ketene compounds | 巴斯夫欧洲公司 | 2020-07-24 | — | — | CN | claimed |
| EP-2931228-B1 | ETHANOL-FREE MICROEMULSION PERFUMING COMPOSITIONS. | FIRMENICH & CIE (CH) | 2018-01-31 | — | — | EP | claimed |
| US-20170267943-A1 | ETHANOL-FREE MICROEMULSION PERFUMING COMPOSITIONS | FIRMENICH SA (CH) | 2017-09-21 | — | — | US | claimed |
| US-9701924-B2 | Ethanol-free microemulsion perfuming compositions | FIRMENICH SA (CH) | 2017-07-11 | — | — | US | claimed |
| US-20150322374-A1 | ETHANOL-FREE MICROEMULSION PERFUMING COMPOSITIONS | FIRMENICH SA (CH) | 2015-11-12 | — | — | US | claimed |
| EP-2931228-A1 | ETHANOL-FREE MICROEMULSION PERFUMING COMPOSITIONS | Firmenich SA (CH) | 2015-10-21 | — | — | EP | claimed |
| US-20150087856-A1 | MELANIN PRODUCTION INHIBITOR | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-03-26 | — | — | US | claimed |
| CN-104334152-A | Melanin production inhibitor | TAKASAGO PERFUMERY CO LTD | 2015-02-04 | — | — | CN | claimed |
| WO-2014090959-A1 | ETHANOL-FREE MICROEMULSION PERFUMING COMPOSITIONS | FIRMENICH SA (CH) | 2014-06-19 | — | — | WO | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| CN-118119589-A | Phenol aromatic compound precursor | 奇华顿股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| US-20240010589-A1 | SUBSTITUTED RESORCINOL COMPOUNDS AS AMPK ACTIVATORS, COMPOSITIONS, METHODS AND USES THEREOF | NESTLE SA (CH) | 2024-01-11 | — | — | US | disclosed |
| WO-1998006803-A1 | RINSE ADDED FABRIC SOFTENING COMPOSITIONS AND METHOD OF USE FOR THE DELIVERY OF FRAGRANCE PRECURSORS | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-19 | — | — | WO | disclosed |
| EP-0097127-A2 | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them | CIBA-GEIGY AG (CH) | 1983-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240010589-A1 | SUBSTITUTED RESORCINOL COMPOUNDS AS AMPK ACTIVATORS, COMPOSITIONS, METHODS AND USES THEREOF | PRKAG2, PRKAG1, PRKAB2 | LMNA 2081/4885 |
| US-20200308094-A1 | PREPARATION OF ACETATE COMPOUNDS VIA A KETENE COMPOUND | AKR1C2, KAT8, KAT5 | LMNA 1601/4885 |
| US-11091424-B2 | Preparation of acetate compounds via a ketene compound | AKR1C2, KAT8, KAT5 | LMNA 1601/4885 |
| US-20150087856-A1 | MELANIN PRODUCTION INHIBITOR | TYR, MITF, MC1R | LMNA 4533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.